相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Synergistic induction of apoptosis in resistant head and neck carcinoma and leukemia by alkoxyamide-based histone deacetylase inhibitors
Leandro A. Alves Avelar et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
A Review of Progress in Histone Deacetylase 6 Inhibitors Research: Structural Specificity and Functional Diversity
Xin-Hui Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Role of Fluorination in the Histone Deacetylase 6 (HDAC6) Selectivity of Benzohydroxamate-Based Inhibitors
Giovanni Sandrone et al.
ACS MEDICINAL CHEMISTRY LETTERS (2021)
Anticancer Therapy with HDAC Inhibitors: Mechanism-Based Combination Strategies and Future Perspectives
Robert Jenke et al.
CANCERS (2021)
Borinostats: solid-phase synthesis of carborane-capped histone deacetylase inhibitors with a tailor-made selectivity profile
Christoph Selg et al.
CHEMICAL SCIENCE (2021)
Novel alkoxyamide-based histone deacetylase inhibitors reverse cisplatin resistance in chemoresistant cancer cells
Yodita Asfaha et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2020)
SynergyFinder: a web application for analyzing drug combination dose-response matrix data (vol 33, pg 2431, 2017)
Aleksandr Ianevski et al.
BIOINFORMATICS (2020)
A patent review of histone deacetylase 6 inhibitors in neurodegenerative diseases (2014-2019)
Sida Shen et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2020)
Role of HDACs in normal and malignant hematopoiesis
Pan Wang et al.
MOLECULAR CANCER (2020)
Metabolic and Pharmaceutical Aspects of Fluorinated Compounds
Benjamin M. Johnson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Multicomponent Synthesis, Binding Mode, and Structure-Activity Relationship of Selective Histone Deacetylase 6 (HDAC6) Inhibitors with Bifurcated Capping Groups
Nina Ressing et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Selective pharmacological inhibitors of HDAC6 reveal biochemical activity but functional tolerance in cancer models
Yves Depetter et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Fluorine-Containing Drugs Approved by the FDA in 2018
Haibo Mei et al.
CHEMISTRY-A EUROPEAN JOURNAL (2019)
Fluorinated Analogues of the Histone Deacetylase Inhibitor Vorinostat (Zolinza): Validation of a Chiral Hybrid Bioisostere, BITE
Nathalie Erdeljac et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
The Dark Side of Fluorine
Yue Pan
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Structural Basis of Catalysis and Inhibition of HDAC6 CD1, the Enigmatic Catalytic Domain of Histone Deacetylase 6
Jeremy D. Osko et al.
BIOCHEMISTRY (2019)
A broad drug arsenal to attack a strenuous latent HIV reservoir
Mateusz Stoszko et al.
CURRENT OPINION IN VIROLOGY (2019)
Structure-Activity and Structure-Toxicity Relationships of Peptoid-Based Histone Deacetylase Inhibitors with Dual-Stage Antiplasmodial Activity
Marcel K. W. Mackwitz et al.
CHEMMEDCHEM (2019)
Design, synthesis and biological evaluation of β-peptoid-capped HDAC inhibitors with anti-neuroblastoma and anti-glioblastoma activity
Nina Ressing et al.
MEDCHEMCOMM (2019)
Marbostat-100 Defines a New Class of Potent and Selective Antiinflammatory and Antirheumatic Histone Deacetylase 6 Inhibitors
Andreas Sellmer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
Nicholas A. Meanwell
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Multicomponent Synthesis and Binding Mode of Imidazo[1,2-a]pyridine-Capped Selective HDAC6 Inhibitors
Marcel K. W. Mackwitz et al.
ORGANIC LETTERS (2018)
Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi
Amila Suraweera et al.
FRONTIERS IN ONCOLOGY (2018)
One-pot, multi-component synthesis and structure-activity relationships of peptoid-based histone deacetylase (HDAC) inhibitors targeting malaria parasites
Daniela Diedrich et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Histone deacetylase 6 in cancer
Ting Li et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Histone Deacetylase 6-Selective Inhibitors and the Influence of Capping Groups on Hydroxamate-Zinc Denticity
Nicholas J. Porter et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Discovery of the First-in-Class Dual Histone Deacetylase-Proteasome Inhibitor
Sanil Bhatia et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
A Dual Modulator of Farnesoid X Receptor and Soluble Epoxide Hydrolase To Counter Nonalcoholic Steatohepatitis
Jurema Schmidt et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
HDAC6 Brain Mapping with [18F] Bavarostat Enabled by a RuMediated Deoxyfluorination
Martin G. Strebl et al.
ACS CENTRAL SCIENCE (2017)
Histone/protein deacetylase 11 targeting promotes Foxp3+Treg function
Jianbing Huang et al.
SCIENTIFIC REPORTS (2017)
SynergyFinder: a web application for analyzing drug combination dose-response matrix data
Aleksandr Ianevski et al.
BIOINFORMATICS (2017)
Identification of HDAC6-Selective Inhibitors of Low Cancer Cell Cytotoxicity
Irina N. Gaisina et al.
CHEMMEDCHEM (2016)
Rational design and diversity-oriented synthesis of peptoid-based selective HDAC6 inhibitors
D. Diedrich et al.
CHEMICAL COMMUNICATIONS (2016)
Inside HDACs with more selective HDAC inhibitors
Joelle Roche et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
HDAC5 controls the functions of Foxp3+ T-regulatory and CD8+ T cells
Haiyan Xiao et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Histone deacetylase 6 structure and molecular basis of catalysis and inhibition
Yang Hai et al.
NATURE CHEMICAL BIOLOGY (2016)
HDAC4 as a potential therapeutic target in neurodegenerative diseases: a summary of recent achievements
Michal Mielcarek et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2015)
In Vivo Imaging of Histone Deacetylases (HDACs) in the Central Nervous System and Major Peripheral Organs
Changning Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Development and Therapeutic Implications of Selective Histone Deacetylase 6 Inhibitors
Jay H. Kalin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs?
Claudia Simoes-Pires et al.
MOLECULAR NEURODEGENERATION (2013)
Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group
Mercedes Lobera et al.
NATURE CHEMICAL BIOLOGY (2013)
Inhibitors for the Immuno- and Constitutive Proteasome: Current and Future Trends in Drug Development
Eva Maria Huber et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2012)
iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM
T. Geoff G. Battye et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2011)
HDAC inhibitors and decitabine are highly synergistic and associated with unique gene-expression and epigenetic profiles in models of DLBCL
Matko Kalac et al.
BLOOD (2011)
Regulation of chromatin by histone modifications
Andrew J. Bannister et al.
CELL RESEARCH (2011)
The Role of HDAC6 in Cancer
Grace I. Aldana-Masangkay et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
Histone Deacetylase Inhibitors: Emerging Mechanisms of Resistance
Robert W. Robey et al.
MOLECULAR PHARMACEUTICS (2011)
MolProbity: all-atom structure validation for macromolecular crystallography
Vincent B. Chen et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2010)
Features and development of Coot
P. Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Paul D. Adams et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2010)
Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphoma
Violetta V. Leshchenko et al.
BLOOD (2010)
Inside HDAC with HDAC inhibitors
Philippe Bertrand
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
Jonathan B. Baell et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
HDAC family: What are the cancer relevant targets?
Olaf Witt et al.
CANCER LETTERS (2009)
Current status of epigenetic treatment in myelodysplastic syndromes
Andrea Kuendgen et al.
ANNALS OF HEMATOLOGY (2008)
Fluorine in medicinal chemistry
Sophie Purser et al.
CHEMICAL SOCIETY REVIEWS (2008)
A Practical Synthesis of a Diazepinylberizoic Acid, a Retinoid X Receptor Antagonist
Xinglong Jiang et al.
ORGANIC PROCESS RESEARCH & DEVELOPMENT (2008)
HDAC6: a key regulator of cytoskeleton, cell migration and cell-cell interactions
Agustin Valenzuela-Fernandez et al.
TRENDS IN CELL BIOLOGY (2008)
Fluorine in pharmaceuticals:: Looking beyond intuition
Klaus Mueller et al.
SCIENCE (2007)
Phaser crystallographic software
Airlie J. McCoy et al.
JOURNAL OF APPLIED CRYSTALLOGRAPHY (2007)
Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (Vorinostat, SAHA) profoundly inhibits the growth of human pancreatic cancer cells
Takashi Kumagai et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
HDAC6 modulates cell motility by altering the acetylation level of cortactin
Xiaohong Zhang et al.
MOLECULAR CELL (2007)
Characterization of the two catalytic domains in histone deacetylase 6
H Zou et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90 - A novel basis for antileukemia activity of histone deacetylase inhibitors
P Bali et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Antileukemia activity of the combination of 5-aza-2′-deoxycytidine with valproic acid
H Yang et al.
LEUKEMIA RESEARCH (2005)
Epigenetics - An epicenter of gene regulation: Histones and histone-modifying enzymes
M Biel et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2005)
The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress
Y Kawaguchi et al.
CELL (2003)
Nonisotopic substrate for assaying both human zinc and NAD+-dependent histone deacetylases
B Heitweg et al.
ANALYTICAL BIOCHEMISTRY (2003)
HDAC-6 interacts with and deacetylates tubulin and microtubules in vivo
Y Zhang et al.
EMBO JOURNAL (2003)
HDAC6 is a microtubule-associated deacetylase
C Hubbert et al.
NATURE (2002)
分享论文
